This study is looking at whether using a uterine manipulator (a device to move the uterus during surgery) during minimally invasive surgery for early stage endometrial cancer (cancer of the lining of the uterus) causes cancer cells to appear in the fluid around the uterus. You would be randomly assigned to one of two groups: one group will have surgery with a uterine manipulator, and the other group will have surgery without one. The study aims to see if there's a difference in the presence of cancer cells in the fluid collected during surgery between these two groups. To join, you must be a woman aged 18 to 90 with suspected early stage endometrial cancer. The study's success will be measured by whether there are cancer cells in the fluid collected during surgery. The current recruitment status is unclear.

Study design

This is a randomized study with 278 planned participants. You would be randomly assigned to one of two groups: surgery with a uterine manipulator or surgery without one.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

The primary endpoint, positive peritoneal cytology, is measured immediately after uterine manipulator placement in one group or prior to hysterectomy in the other.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.